Frontier is thrilled to announce a partnership with Injective Protocol, A Layer-2 Decentralised exchange that further unlocks the full potential of decentralized derivatives and borderless DeFi.
Speaking about the partnership, Eric Chen, Co-founder, and CEO at Injective Protocol said that
Frontier is unlocking a new paradigm in the DeFi sector by allowing mainstream traders and crypto users to access DeFi networks with ease. This is a major step for Injective as we look to integrate our derivatives DEX with Frontier, enabling millions of new potential users to utilize the tech built by the Injective team.
Frontier CEO and Co-founder, Ravindra Kumar is excited to be able to access the derivative markets offered by Injective.
We have been following Injective’s progress for quite some time and are immensely excited to bring our users unique derivatives markets. This will enable a host of new opportunities for trading swaps across a multitude of new asset types.
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective Protocol is backed by a prominent group of stakeholders including Pantera Capital, one of the most renowned venture capital firms in the world, and the leading cryptocurrency exchange, Binance.
Learn more about Injective Protocol here
Frontier is a chain-agnostic DeFi aggregation layer. To date, we have added support for DeFi on Ethereum, Binance Chain, BandChain, Kava, and Harmony. Via StaFi Protocol, we will enter into the Polkadot ecosystem, and we will now put vigorous efforts toward Serum.
With our applications, users can participate in protocol tracking and management, staking, best-rate asset swapping, liquidity provision, CDP creation, and monitoring, and more.